Literature DB >> 20098444

Reproductive endocrinology: live birth prediction in polycystic ovary syndrome.

Shahla Nader1.   

Abstract

Anovulatory infertility is common in polycystic ovary syndrome (PCOS). Clinicians who provide first-line treatment have to decide how best to induce ovulation with the desired outcome of live birth, a decision often complicated by the phenotypic heterogeneity of PCOS. could a new livebirth prediction model of different ovulation induction methods developed from basic clinical parameters help select infertility treatments?

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20098444     DOI： 10.1038/nrendo.2009.251

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  10 in total

1.  Early Origins of polycystic ovary syndrome: hypotheses may change without notice.

Authors:  Francis de Zegher; Lourdes Ibáñez
Journal:  J Clin Endocrinol Metab       Date:  2009-10       Impact factor: 5.958

2.  Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial.

Authors:  Etelka Moll; Patrick M M Bossuyt; Johanna C Korevaar; Cornelis B Lambalk; Fulco van der Veen
Journal:  BMJ       Date:  2006-06-12

3.  Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial.

Authors:  S Eisenhardt; N Schwarzmann; V Henschel; A Germeyer; M von Wolff; A Hamann; T Strowitzki
Journal:  J Clin Endocrinol Metab       Date:  2005-12-13       Impact factor: 5.958

Review 4.  The role of metformin in polycystic ovary syndrome: a systematic review.

Authors:  Etelka Moll; Fulco van der Veen; Madelon van Wely
Journal:  Hum Reprod Update       Date:  2007-09-01       Impact factor: 15.610

Review 5.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

6.  Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.

Authors:  Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Christos Coutifaris; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

7.  Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome.

Authors:  Stefano Palomba; Francesco Orio; Angela Falbo; Tiziana Russo; Achille Tolino; Fulvio Zullo
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

8.  Predictors of pregnancy in women with polycystic ovary syndrome.

Authors:  Mary E Rausch; Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers; Christos Coutifaris
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

9.  Consensus on infertility treatment related to polycystic ovary syndrome.

Authors: 
Journal:  Hum Reprod       Date:  2008-03       Impact factor: 6.918

Review 10.  Adrenarche and polycystic ovary syndrome: a tale of two hypotheses.

Authors:  Shahla Nader
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-12       Impact factor: 1.814
  10 in total
  1 in total

1.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.